Pulmonary surfactant formulations and methods for promoting mucus clearance
US8221772B2 · kind B2 · utility
4Cited by
28References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2007 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Sep 19, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions to enhance mucus clearance and to treat pulmonary lung disorders such as cystic fibrosis are disclosed. The methods utilize compositions including synthetic pulmonary surfactants having one or more phospholipids and a synthetic polypeptide, administered alone or combined with hyperosmotic agents, to patients in an amount effective to enhance mucus clearance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.